Tallal Younis

Impact of the 2013 <scp>A</scp>merican <scp>S</scp>ociety of <scp>C</scp>linical <scp>O</scp>ncology/<scp>C</scp>ollege of <scp>A</scp>merican <scp>P</scp>athologists guideline recommendations for human epidermal growth factor receptor 2 (<scp>HER</scp>2) testing of invasive breast carcinoma: a focus on tumours assessed as ‘equivocal’ for <scp>HER</scp>2 gene amplification by fluorescence <i>in‐situ</i> hybridization

Gillian Bethune, Daniel Veldhuijzen van Zanten, Rebecca F. MacIntosh et al. · Histopathology · 2015 · 62 citations

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

Nathan Lamond, Chris Skedgel, Daniel Rayson et al. · Breast Cancer Research and Treatment · 2012 · 60 citations

Node-positive Breast Cancer, 21-Gene Recurrence Score, Oncology +9

Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study

Daniel Rayson, Jennifer Payne, Mohamed Abdolell et al. · Clinical Breast Cancer · 2011 · 51 citations

Clinical-pathologic Characteristics, Breast Oncology, Cancer Epidemiology +11

Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations

Alwin Jeyakumar, Tallal Younis · Clinical Medicine Insights Oncology · 2012 · 49 citations · Full text

Breast Oncology, Health Sciences, Medicine +13

Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)

Xiang Ling, Jie Yang, DongFeng Tan et al. · Lung Cancer · 2005 · 44 citations · Full text

Disease Relapse, Non-small-cell Lung Cancer, Differential Expression +10